look at the a business news and marcus carson is here. first up, is fisa really giving up on astrazeneca? -- is pfizer billy giving up on astrazeneca? -- really giving up on astrazeneca? bid to have raised the $118 billion, calling its offer its last. the news ofed on this renewed rejection. we asked michael hewson from cmc markets in london whether this is the end of pfizer's astrazeneca aspirations. >> judging by the market reaction this afternoon and today, this would appear to be the case. we have seen a lot of money flow out of astra zeneca shares, and that was really all of the money that had flowed into it on the expectation that pfizer would come back with a much better offer. have come back with a much better offer and astra zeneca have turned it down. what is going to happen now is that it is dependent on what astra zeneca shareholders do next. >> do you think there is a chance that astra zeneca shareholders will turn around and put pressure on the board of the company to go back to the negotiating table to engage again with pfi